What changed in Australian cosmetic advertising in 2025
Cosmetic procedure advertising in Australia sits under real, actively-tightening regulation. AHPRA's cosmetic procedure advertising guidelines — which took effect on 2 September 2025 — strengthened an already-strict testimonial ban under National Law s133 to explicitly cover influencer content and re-shared patient stories, banned apps or tools that predict a person's post-procedure appearance, prohibited advertising cosmetic procedures to under-18s outright, and introduced a mandatory 7-day cooling-off period between a first consultation and any procedure for under-18 patients. Separately, since 1 July 2023 the title “surgeon” (including “cosmetic surgeon”) is legally protected — only specialist-registered surgeons may use it. On top of the AHPRA layer, the Therapeutic Goods Administration (TGA) separately prohibits advertising prescription-only medicines — including named injectable brands — to the public under the Therapeutic Goods Act 1989.
This self-check walks your actual ad copy through the risk areas that most often trip up cosmetic clinic advertising in Australia, flags the specific phrase that triggered each one, explains which rule it touches, and suggests a compliant rewrite. It's the same discipline our performance marketing team applies when building campaigns for regulated clinic accounts — compliance and performance are one job, not two. Use it as a first pass, then confirm anything borderline against AHPRA's own published guidance or your adviser.
What this checker looks for
Nine rule categories, drawn from the sources cited above — each one covers a specific pattern our checker scans your pasted text for:
- Testimonials (patient or influencer) — The National Law (s133) prohibits testimonials in health service advertising outright. AHPRA's 2 September 2025 cosmetic procedure guidelines specifically strengthened this to also ban re-shared patient stories and social-media-influencer testimonials, including time-limited formats like Stories. Source
- Influencer / social media testimonials — AHPRA's September 2025 guidelines specifically strengthened the ban on testimonials sourced from social media influencers for cosmetic procedures — this applies even when the practitioner did not write the content themselves and only re-shared or boosted it. Source
- Before/after imagery — AHPRA guidance prohibits before-and-after imagery that creates an unrealistic expectation of beneficial treatment for higher-risk cosmetic procedures. Source
- Appearance-prediction tools — The September 2025 guidelines specifically prohibit advertising higher-risk cosmetic procedures using automated apps, websites, tools or programs that predict a person's appearance post-procedure (or predict their appearance without the procedure). Source
- Advertising to under-18s — AHPRA's September 2025 guidelines ban advertising cosmetic procedures to individuals under 18, and impose a mandatory 7-day cooling-off period between a first consultation and any procedure for under-18 patients where a procedure is clinically appropriate at all. Source
- Discounts, gifts & time-limited inducements — Advertising a regulated health service with a gift, discount or other inducement must clearly state the offer's terms and conditions in plain language. Manufactured urgency around a clinical decision is separately discouraged as creating an unreasonable expectation or pressuring the decision. Source
- "Surgeon" / "cosmetic surgeon" title — Since 1 July 2023, the title "surgeon" (including "cosmetic surgeon") is legally protected — only a medical practitioner with specialist registration in surgery, obstetrics and gynaecology, or ophthalmology may use it. A cosmetic surgery endorsement alone does not permit use of the title. Source
- Guarantees & unreasonable expectations — Advertising must not create an unreasonable expectation of beneficial treatment, and unverifiable superlative or guarantee-style claims about a clinical outcome are a recurring AHPRA enforcement trigger under s133's general standard. Source
- Naming a prescription-only product (TGA) — The Therapeutic Goods Act 1989 prohibits advertising prescription-only medicines to the public, with very limited exceptions. This includes naming a specific prescription injectable or weight-loss medication brand in consumer-facing advertising — the TGA treats this as a reference to a prescription medicine regardless of context. Source
Methodology — where this checklist comes from
Each rule is sourced directly from AHPRA's own published cosmetic procedure advertising guidance (ahpra.gov.au) and the TGA's advertising-to-the-public restrictions (tga.gov.au), linked above per rule. It is not a substitute for legal advice: treat a “no flags” result as a reasonable first pass, not clearance, and confirm anything borderline with AHPRA, the TGA, or your own adviser before publishing. Running a Malaysian clinic instead? Use our KKM ad checker.
Rules current as of: July 2026